MAPT and Alzheimer disease: The various models of the AD pathological cascade, incorporating tauopathies and amyloidopathies, reveal different timelines for the evolution of amyloid beta or tau pathologies, where this has been investigated post-mortem [17], and/or tracked in mutation carriers [17,18].